Misperception among physicians and patients regarding the risks and benefits of statin treatment: the potential role of direct-to-consumer advertising

Patients with elevated liver enzymes are not at higher risk for statin hepatotoxicity

Naga Chalasani, Hisham Aljadhey, Joe Kesterson et al. · Gastroenterology · 2004 · 437 citations

Higher Risk, Hepatology, Liver Physiology +9

Promotion of Prescription Drugs to Consumers

Meredith B. Rosenthal, Ernst R. Berndt, Julie M. Donohue et al. · New England Journal of Medicine · 2002 · 424 citations

Fatty Infiltration of Liver in Hyperlipidemic Patients

Nimer Assy, Kelly Kaita, David Mymin et al. · Digestive Diseases and Sciences · 2000 · 361 citations

An Assessment of Statin Safety by Hepatologists

David E. Cohen, Frank A. Anania, Naga Chalasani · The American Journal of Cardiology · 2006 · 348 citations

Hepatology, Hepatotoxicity, Liver Disease +4

Better Knowledge Improves Adherence to Lifestyle Changes and Medication in Patients with Coronary Heart Disease

Carin Alm‐Roijer, Martin Stagmo, Giggi Udén et al. · European Journal of Cardiovascular Nursing · 2004 · 189 citations